Medtronic (NYSE:MDT) reported earnings earlier this week, and the news was generally in-line with expectations (revenue slightly missed, off $10 million or $20 million from analyst expectations, depending on the source). At $4.6 billion, revenue was up 3% in constant currency, with $571 million coming from emerging markets, up 14% in constant currency. Medtronic guided for 3% to 5% revenue growth and 6% to 9% earnings growth in constant currencies.

With the litigation around CoreValve finished, Medtronic has some interesting opportunities ahead. In this video, from Market Checkup, the Motley Fool's health care-focused investing show, health care analysts David Williamson and Michael Douglass discuss the earnings and key takeaways for investors.